Product Images Vestura

The text consists of a list of studies with their hazard ratio, rate ratio, and odds ratio. The studies include Ingenix, EURAS, LASS, an FDA-funded study, a Danish study, a Danish re-analysis, MEGA study, German case-control, PharMetrics, and GPRD study. There is no additional information available.*

This is a list of various methods of birth control and their efficacy rates. The efficacy rates are provided in terms of the number of pregnancies per 100 women in one year for each method. The methods listed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. The efficacy rates vary greatly between the different methods.*

This text provides information regarding the likelihood of developing a serious blood clot. It shows ranges for women who are non-pregnant and non-COC users, women who use COC, and women who are pregnant (only up to 12 weeks). The data is presented as the number of women with a blood clot out of 10,000 Women Years. The rate of blood clot occurrence for pregnant women is based on the actual duration of pregnancy and the assumed pregnancy duration of nine months.*

Vestura tablets are oral contraceptives that contain drospirenone and ethinyl estradiol to prevent pregnancy. This medication does not protect against HIV infection or other sexually transmitted diseases. It comes in 3 mg/0.02 mg, with each package containing 28 tablets. The product code is NDC 0093-4000-62.*